These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
209 related items for PubMed ID: 15081015
21. Large ring 1,3-bridged 2-azetidinones: experimental and theoretical studies. Urbach A, Dive G, Tinant B, Duval V, Marchand-Brynaert J. Eur J Med Chem; 2009 May; 44(5):2071-80. PubMed ID: 19038477 [Abstract] [Full Text] [Related]
33. Prolyl oligopeptidase inhibition by N-acyl-pro-pyrrolidine-type molecules. Kánai K, Arányi P, Böcskei Z, Ferenczy G, Harmat V, Simon K, Bátori S, Náray-Szabo G, Hermecz I. J Med Chem; 2008 Dec 11; 51(23):7514-22. PubMed ID: 19006380 [Abstract] [Full Text] [Related]
34. Novel potent hepatitis C virus NS3 serine protease inhibitors derived from proline-based macrocycles. Chen KX, Njoroge FG, Arasappan A, Venkatraman S, Vibulbhan B, Yang W, Parekh TN, Pichardo J, Prongay A, Cheng KC, Butkiewicz N, Yao N, Madison V, Girijavallabhan V. J Med Chem; 2006 Feb 09; 49(3):995-1005. PubMed ID: 16451065 [Abstract] [Full Text] [Related]
39. Dibasic inhibitors of human mast cell tryptase. Part 2: structure-activity relationships and requirements for potent activity. Rice KD, Wang VR, Gangloff AR, Kuo EY, Dener JM, Newcomb WS, Young WB, Putnam D, Cregar L, Wong M, Simpson PJ. Bioorg Med Chem Lett; 2000 Oct 16; 10(20):2361-6. PubMed ID: 11055356 [Abstract] [Full Text] [Related]
40. Factor VIIa inhibitors: target hopping in the serine protease family using X-ray structure determination. Shiraishi T, Kadono S, Haramura M, Kodama H, Ono Y, Iikura H, Esaki T, Koga T, Hattori K, Watanabe Y, Sakamoto A, Yoshihashi K, Kitazawa T, Esaki K, Ohta M, Sato H, Kozono T. Bioorg Med Chem Lett; 2008 Aug 15; 18(16):4533-7. PubMed ID: 18674905 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]